Physician profile
Christopher Mckinnie
NPI 1962906727
$3,184.41
in general payments reported to CMS, 2019-2025
21 companies · $424 in 2025
The $424 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $445 · 2023: $1,040 · 2024: $992 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,456.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $660.81 | 2023-2025 | Ensite Precision, Merlin@Home, Fortify Assura |
| Amgen INC. | $392.42 | 2021-2025 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $384.21 | 2021-2024 | Farxiga, Andexxa |
| Novartis Pharmaceuticals Corporation | $343.11 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $312.84 | 2021-2024 | Lifevest |
| Boston Scientific Corporation | $237.07 | 2021-2023 | S-Icd System Magnet |
| Pfizer INC. | $204.21 | 2022-2025 | |
| Medtronic, INC. | $153.02 | 2022-2023 | Azure Xt Dr Mri Surescan, Micra |
| Janssen Pharmaceuticals, INC | $113.54 | 2024 | Xarelto |
| Novo Nordisk INC | $101.71 | 2023-2025 | Wegovy, Ozempic |
| Edwards Lifesciences Corporation | $62.72 | 2025 | Pascal |
| Actelion Pharmaceuticals US, INC. | $32.65 | 2024 | Uptravi |
| Lexicon Pharmaceuticals, INC. | $28.08 | 2024 | |
| Lantheus Medical Imaging, INC. | $23.52 | 2022 | |
| Livanova USA, INC. | $22.06 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.82 | 2022 | |
| Esperion Therapeutics, INC. | $20.38 | 2021 | |
| Alnylam Pharmaceuticals INC. | $19.55 | 2023 | Onpattro |
| Biotronik INC. | $18.48 | 2022 | |
| Inari Medical, INC. | $16.22 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Scientific Affairs, LLC | $15.99 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mckinnie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.